Asthma is a common disease in childhood with a minority of affected children having severe therapy-resistant asthma (STRA). Children with STRA can be differentiated from those with mild-moderate disease by greater allergic sensitization, increased eosinophilic airway inflammation, increased airway remodelling and reduced corticosteroid responsiveness. The aetiology of STRA in children is multifactorial but allergy seems to play a key role. Many children with asthma have coexisting allergic disease, and severe rhinitis seems to be an important driver of STRA in children. Allergies to foods, moulds, pollen and pets have also been associated with severe asthma exacerbations. Identifying allergens that are driving asthma symptoms in children with STRA may provide additional strategies for improving their disease control. Avoidance strategies may be possible. Additional monoclonal antibody therapy with Omalizumab or Mepolizumab may be helpful in children with clinically important polysensitization.
| INTRODUCTION
Asthma is the most common chronic lung disease of childhood and affects approximately 25% of children in the United Kingdom. 1 Fortunately, most children with asthma achieve good symptom control with low-dose inhaled corticosteroid (ICS). Some children have asthma that is difficult to treat despite high doses of ICS and additional controller medications due to modifiable factors, commonly poor adherence to ICS or persistent exposure to environmental triggers. 2 These children with "difficult asthma" account for up to 97% of referrals to paediatric asthma clinic and can achieve good symptom control if these modifiable factors are adequately addressed. 3 However, 2%-5% of children with asthma remain symptomatic despite addressing modifiable factors and treatment with high-dose ICS, long-acting β2-receptor agonists, leukotriene receptor antagonists and occasionally systemic corticosteroids. [4] [5] [6] [7] [8] [9] These children have "severe therapy-resistant asthma" (STRA) (Box 1). 10 Despite the low prevalence of STRA, it accounts for significant morbidity and almost 50% of total asthma-related expenditure. 5, 7, 11 It is imperative that children with difficult asthma undergo thorough assessment to identify and address modifiable factors before undergoing invasive investigations and further escalation of potentially harmful treatments for STRA. 12 This involves confirming the diagnosis of asthma by demonstrating variable and reversible airflow obstruction, [13] [14] [15] ensuring adherence to treatment by checking general practitioner prescription records and that the appropriate inhalers are available on the home visit 2, 16 and checking the child's inhaler technique. 17 It is also necessary to minimize exposure to environmental allergens where possible, 2 avoid pollutants including cigarette smoke 13 and manage comorbidities including obesity, 9 dysfunctional breathing and vocal cord dysfunction, allergic rhinitis and food allergy. 18, 19 Clinically, children with STRA are differentiated from those with mild-moderate disease by greater allergic sensitization, increased eosinophilic airway inflammation, increased airway remodelling, reduced lung function and reduced corticosteroid responsiveness. 2, 20, 21 This is further complicated because children with STRA are themselves a heterogeneous group in terms of lung function, inflammation and allergic sensitization, and different phenotypes of STRA are being recognized. 2, 20, [22] [23] [24] [25] Improving our understanding of the factors driving STRA may allow better targeting of therapy and potentially improve outcomes. 26 
| STRA AND ALLE RGY
Allergy is likely to be an important factor involved in STRA as children with more severe asthma are more atopic (have more allergic sensitizations), and tend to be exposed to higher levels of allergens to which they are sensitized when compared with children with mild asthma. 13, 27 Plus the greater the number of organ systems affected by allergy, the worse the prognosis of each of the allergic diseases (e.g eczema, food allergy), and particularly asthma. 28 It is plausible that persistent exposure to allergens, which may also manifest as rhinitis, eczema or food allergy, may drive airway inflammation and STRA. Reducing exposure to environmental allergens and anti-IgE therapy are both effective in managing STRA thereby supporting this hypothesis. 14, 18 In this review, we examine the hypothesis that asthma is an allergic disease of the airways and propose that allergy is a key determinant of STRA (see Appendix S1 for search strategy). The role of allergic comorbidities and environmental allergen exposure in STRA will be the focus of this review. Diagnosing asthma in preschool children that wheeze is challenging, so we do not consider this age group here.
The terms "difficult asthma" and STRA (Box 1) are becoming more widely adopted in publications, allowing results to be compared and conclusions drawn. Unfortunately, the vague term "severe asthma" is still used relatively indiscriminately in some publications to describe children with any features of more severe asthma based on reported symptoms, treatment requirements, frequency of exac- confidence interval (CI) 2.05-6.00), and there was a significant positive correlation between increasing AR severity and asthma severity (P < 0.001).
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The "unified airway" concept suggests that upper airway disease (AR) and lower airway disease (asthma) are both manifestations of the same IgE-dependent eosinophilic inflammatory process, being driven primarily by exposure to inhalant allergens. 19, 34, 43 The association between AR and asthma severity could then be explained by the larger burden of inflammation seen when both conditions are present. It is also possible that the relationship between AR and asthma could be, at least in part, causal. One study confirmed that the association between AR and SA remained significant even after adjustment for total serum IgE and polysensitization to aeroallergens, suggesting rhinitis may directly impact on asthma severity. 30 Studies showing that provocation of nasal mucosa with allergen in patients with AR caused pulmonary symptoms and decreased airway function, and similarly segmental bronchial provocation triggered nasal inflammation, support the unified airway concept. 34, 44, 45 AR may also be causally linked to asthma severity through impaired function of the upper airways, which includes filtering, warming and humidifying air before it reaches the lower airways. 19, 34, [45] [46] [47] This idea is supported by findings of significantly impaired lung function in children with moderate-severe persistent rhinitis, compared to mild intermittent rhinitis, in children without overt asthma symptoms, which was independent of atopic status. 48 Nasal obstruction due to AR necessitates mouth-breathing which may result in bronchial hyperreactivity due to cold dry air, and greater delivery of allergens to the lower airways. 44, 46 These mechanisms may underlie the relationship between AR and STRA. 
| Eczema
Eczema affects 15%-38% of children and usually precedes the onset of asthma. 28, [52] [53] [54] [55] [56] The filaggrin gene has been identified as important in eczema, with loss-of-function mutations being associated with skin barrier dysfunction and an increased incidence of asthma. 52, 54 In one birth cohort study, eczema with filaggrin loss-of-function mutations was associated with STRA and reduced lung function at puberty. 22 We can speculate that ongoing exposure of eczematous skin to allergens may result in the development of polysensitization, driving systemic allergic inflammation and worsening of asthma symptoms.
Alternatively, the association between eczema and asthma may not be causal. Randomized controlled trials (e.g ClinicalTrials.gov NCT02449850) of skin barrier agents are now ongoing and may provide more information in time.
| Food allergy
Food allergy (FA) affects 2.5%-4.2% of all children and 10% of children with asthma and is associated with asthma severity, including more night-time symptoms, higher steroid requirements, more frequent asthma exacerbations and more hospital and intensive care admissions. 18, 55, [57] [58] [59] In a prospective study of 174 children <36 months old sensitized to food and aeroallergens on SPT, followup 7-14 years later showed those with persistent food and aeroallergen sensitization had much more severe asthma compared with those that had only aeroallergen sensitization. 57 In the National
Cooperative Inner City Asthma Study, children aged 4-9 years with asthma and food sensitization on sIgE testing had significantly higher rates of hospitalization and required significantly more steroid medication than those not sensitized to food. 60 A study by Roberts et al found children with acute life-threatening asthma requiring ventilation were much more likely to have clinical FA than those attending the emergency department with non-life-threatening exacerbations. 61 Additionally, a study of 201 children with asthma found peanut and milk allergy were independently associated with hospitalizations for asthma exacerbations. 62 In other studies, multiple food allergies have been associated with STRA 16, 60, 62 It is not clear whether the observed relationship between STRA and FA is due solely to a shared stronger atopic tendency, or whether a causal pathophysiological link is responsible. 63 Several mechanisms have been proposed for a causal link. Firstly, some anaphylactic reactions to food may be misdiagnosed as acute exacerbations of asthma, especially where exercise is a cofactor for severe reactions to food. 58, 61, 63, 64 In a retrospective analysis of the records of 73 children admitted to intensive care with asthma, a diagnosis of anaphylaxis was considered possible in 17.8% and highly likely in 4.1%. 64 Secondly, ingestion of food allergens in some children may cause a less severe allergic reaction manifesting primarily as worsening of asthma symptoms. Whilst FA manifesting as asthma is thought to be rare, it has been reported that ingestion of food allergens in children with asthma can trigger asthma symptoms up to 30% of the time. 55, 58 Thirdly, it has been proposed that chronic inhalation of aerosolized food allergens may increase asthma severity. 61, 63 Occupational asthma in adults is widely recognized, with Baker's asthma being most commonly due to inhalation of airborne flour in those with wheat allergy, though milk powder, egg, carob bean and soya flour have also been implicated. 61, 63 The pathophysiology and histological findings of occupational and allergic asthma in adults are similar, but studies in children were not identified. 63 Despite the uncertain nature of the relationship between STRA and FA, having both conditions is a risk factor for increased morbidity and mortality, so accurate diagnosis of FA in children with STRA is essential and both conditions should be managed optimally. 55, 65 Referral to a dietician for education on food avoidance, reading of food labels, appropriate food substitutions and monitoring of growth is recommended. Regular patient and parent education regarding appropriate treatment of allergic reactions including autoinjector use are vital, since many fatal cases could have been avoided by more prompt adrenaline administration. 66 Optimal asthma management and compliance with treatment are needed to reduce the risk of fatal food-related anaphylaxis associated with accidental exposure. 66 
| STRA AN D E NVIRONMENTAL AEROALLERGE NS
Common aeroallergens include HDM (Dermatophagoides pteronyssinus and farinae), cat, dog and mouse epithelium, grass, tree and weed pollens, and moulds (Aspergillus fumigatus, Alternaria alternata, Cladosporium herbarum and others). [67] [68] [69] In warmer climates cockroach, rice dust, mosquito and housefly sensitization are also common. 70 
| House dust mite
In the UK, 65% of children with asthma are sensitized to HDM, 71 and exposure to HDM results in asthma symptoms. 72, 73 In a randomized study of 82 children with asthma, there was a positive linear association between increasing asthma severity and response to chemical HDM control measures, suggesting that HDM exposure is important in driving asthma symptoms. 74 A study of 546 inner-city adolescents with moderate-severe asthma found that higher HDM levels correlated with reduced lung function, higher airway inflammation and a greater risk of asthma exacerbation and hospitalization. 75 The management of children with asthma who are HDM sensitized involves attempts to minimize exposure to HDM in the home, pharmacotherapy to reduce the allergic response, and occasionally immunotherapy to induce tolerance and modify the disease process if asthma is not severe. 68, 72, 76 Not all methods of reducing exposure to HDM have been demonstrated to work. 77, 78 However, a doubleblind randomized controlled trial of mite-impermeable or placebo bedding covers used for 12 months in children sensitized to HDM, after a recent emergency hospital attendance for asthma, showed mite-impermeable covers halved the risk of emergency hospital attendance. 71 In this study, there was no reduction in the frequency of prednisolone use for exacerbations, but given the relatively low cost of the intervention and reduction in severe exacerbations requiring hospitalization, mite-impermeable covers should be recommended for children with asthma and HDM sensitization.
| Pets
Allergy to cats and/or dogs is associated with increased bronchial hyperresponsiveness and airway inflammation and is considered to be a risk factor for ongoing asthma morbidity. [79] [80] [81] In children sensitized to their pet, pet allergen levels in house dust samples have been associated with asthma severity. 82 In a study of 963 adolescents in Sweden, there was a highly significant positive relationship between sIgE titres to dog or cat allergens and asthma severity, measured by frequency of asthma exacerbations and medication use. 83 In a study comparing children with severe and controlled asthma, the frequency of sensitization to cat, dog and horse on SPT was similar between the groups but the levels of animal sIgE were significantly higher in the severe group, and they were more likely to be triple sensitized to the three animals. 80 Polysensitization to animals has been reported elsewhere to be associated with increased asthma severity in children. 84 It is increasingly being recognized that pet allergens are readily transferred and exposure is ubiquitous in homes, schools and indoor public spaces. 34, 68, 80, 83 A study of 831 homes in the United States found cat and dog allergens in dust samples from >90% of homes, despite only 32% of homes having a dog and 24% having a cat. 82 In the Swedish study, 50% of the adolescents with persistent asthma sensitized to cat or dog lived in a home with no animals, and 85% of those with asthma sensitized to cat had no cat at home. 83 Even small amounts of cat allergen on the clothes of classmates at school is sufficient to cause asthma deterioration in some children. 14 Therefore, sensitization to cat and/or dog may also be contributing to worse asthma control in children from pet-free homes. These studies suggest pet exposure in sensitized children may be a driver of STRA, and all children with STRA, regardless of presence or absence of pets in the home, should be routinely tested for sensitization to cats and dogs. 80, 85 Judging the impact that pet exposure has on a child's asthma is very difficult as it is impossible to entirely eliminate pet allergen exposure, and an improvement in asthma symptoms on removing the child from the home with the pet is typically only seen after 2-3 weeks. 73 Also, when pets have been in the household for a long time, early-phase histamine-mediated immediate symptoms, for example itch, may be abolished, but the late-phase asthma response persists. Caregivers may then not recognize the impact of the pet on their child's asthma and so may under-report symptoms. Measures that can effectively reduce pet allergen load, including high-efficiency vacuum cleaners and air filtration systems, have been shown to improve asthma control in sensitized children. 81 In a study of adults with pet allergy and asthma, those that removed the pets from their home required less medication and had less bronchial hyperresponsiveness at follow-up compared to those that kept their pets. 82 Similar studies in children were not found. We know that many people continue to live with a pet despite being allergic and removal of the pet from the household can have a dramatic psychological impact on a child. 80, 82 The lack of published evidence makes it difficult to insist families remove household pets, but for children with STRA and significant sensitization on SPT and sIgE, it would seem sensible to recommend rehoming the pet, at least for a trial period.
Several studies have investigated whether early regular exposure to pets in the home could reduce allergic sensitization and asthma development in children. 83 Results suggest being raised in a home with a cat does not increase the risk of sensitization or asthma development, but no benefit in terms of developing tolerance to cats/dogs has been consistently demonstrated. 86, 87 For now, advice
should not be given to avoid or specifically acquire pets for primary prevention of asthma or pet allergies. 86 Increasingly, the impact of exposure to pests, particularly in low socioeconomic areas, on asthma severity in children is being understood. Mouse allergen is common in inner-city homes and schools, and high allergen load is associated with significantly increased hospital presentations, reduced spirometry and bronchodilator reversibility, increased baseline asthma treatment and increased Composite Asthma Severity Index (CASI). 68, 88, 89 Similarly, cockroach exposure is common in inner-city homes in the United States and some areas of Europe and has been associated with asthma severity. 90, 91 Successful reduction in cockroach exposure using insecticidal bait in the homes of children with moderate-severe asthma was associated with a significant reduction in frequency of asthma symptoms, health care utilization and missed school days due to asthma symptoms. 92 In children with STRA, investigation to detect sensitization and level of exposure to pests should be considered, particularly in low socioeconomic areas, and exposure minimized through pest management. However, this strong association between fungal sensitization and STRA is not demonstrated in all studies. 100 The Melbourne Air Pollen Children and Adolescent Study investigated 644 children hospitalized for asthma and found exposure to ambient levels of Alternaria and other common fungal spores was significantly associated with hospitalizations for asthma. 101 At the time of hospitalization, 69% were infected with human rhinovirus (HRV), but the risk associated with ambient mould levels remained after controlling for HRV infection, suggesting moulds and viruses act synergistically to increase exacerbation risk. This risk was also independent of ambient pollen and pollution levels, and the effects were seen up to 3 days after exposure. The increased risk of hospitalization was seen in children with asthma with and without fungal sensitization measured by SPT, and whilst the risk appeared higher in those sensitized, this did not reach statistical significance. In an international cross-sectional study of 46 051 children, asthma symptoms and exposure to damp spots or moulds in the house were assessed by parental questionnaire, and exposure to damp or moulds was associated with greater severity of wheeze, but not bronchial hyperresponsiveness, in children regardless of atopic status. 102 Other studies have similarly found that exposure to moulds is associated with asthma severity in atopic and nonatopic children. 103 The pathophysiology underlying the observed link between STRA and moulds is not clear but several mechanisms have been proposed.
Firstly, it has been assumed that an inflammatory response occurs in the airways of sensitized children in response to exposure to allergenic components of environmental fungi. 104 Secondly, long-term colonization or infection of the airways with allergenic fungi could provide a persistent source of allergen exposure and trigger proinflammatory host defence mechanisms. 96, 98, 104, 105 Severe asthma with fungal sensitization (termed SAFS) may represent a discrete phenotype of STRA, with properties similar to allergic bronchopulmonary aspergillosis (ABPA) in adults, and possible improvement with antifungal therapies. 24, [104] [105] [106] SAFS is typically associated with worse inflammation than other phenotypes of STRA despite more asthma treatment. 9 It has even been reported that chronic fungal infection of the skin and nails can exacerbate asthma, with improvement in asthma symptoms and lung function on treatment of the infection. 24 Thirdly, it has been proposed that some fungal antigens can trigger autoimmune reactions, when an immune response targeting a fungal protein also targets the closely related human counterparts, potentially exacerbating airway inflammation. 24 Finally, moulds in indoor environments, including bedding, are known to release volatile components that may irritate the respiratory mucosa and increase asthma severity independently of allergic mechanisms. 24 There are several possible explanations for the inconsistent relationship between STRA and fungal sensitization. Fungal spores are ubiquitous in indoor and outdoor environments but levels vary with geographical area and weather/climate conditions, so it can be difficult to establish a link between exposure and asthma symptoms. 69, 96, 101 The link is also complicated by a degree of crossreactivity between the different fungal species and the fact that many children are polysensitized to various moulds and pollens with overlapping seasons. 67, 101 Accurately detecting fungal sensitization is complicated by variable use of SPT and sIgE in different studies and a lack of standardized reagents for SPT. Many studies have not considered degree of sensitization or quantified exposure to moulds and have relatively small sample sizes. 101 Finally, exposure to moulds may drive STRA in some children through a combination of allergic and nonallergic mechanisms outlined above. More research is needed to understand which of these mechanisms are responsible for the relationship between STRA and moulds in children.
In children with STRA, it is important to assess for mould sensitization and exposure so appropriate avoidance measures can be taken. A combination of SPT and sIgE quantification are recommended as together they can accurately predict clinical reactivity. 24 Management of SAFS can be difficult as spore concentrations can be unpredictable and exposure difficult to avoid. 69 Advice regarding potential risk situations such as thunderstorms and handling mouldy vegetation should be given to mitigate the effects of outdoor exposures. 67 Evidence for a potential benefit of antifungal therapy in SAFS is very limited, 24 and techniques for fungal culture from sputum and bronchoalveolar lavage have low sensitivity for detecting infection. 99 Whilst case reports are positive, randomized controlled trials are needed to understand the role of antifungals in SAFS.
| Pollens
Pollen is known to be a strong trigger for seasonal AR and conjunctivitis and has been reported to trigger asthma exacerbations in sensitized children. 34 In a study in Atlanta, ambient grass and tree pollen levels contributed to asthma morbidity in children, with a significant 10%-15% increase in emergency department attendances for asthma on the days with the highest pollen concentrations. 107 Other studies have shown similar results. 108 A recent meta-analysis showed small increases in grass pollen levels (of 10 grass pollen grains per cubic metre) are associated with a significant increase in mean number of asthma exacerbations in children presenting to the emergency department. 109 Pollen levels can vary considerably throughout the year, with levels up to 100 grains/m³ resulting in an increase in ED presentations of 18.8%. 109 A 3-day lag is frequently reported between peak pollen levels and peak asthma admissions. 109 Pollen allergy also demonstrates a synergistic relationship with viral infections, as respiratory viral infections are more likely to be associated with severe asthma exacerbations requiring hospitalization when ambient grass pollen concentrations are high. 34, 110, 111 Pollens are much larger than HDM and mould allergens and are more likely to be filtered out by the upper airway so less penetrates the lower airways. 34 This may explain why pollen allergy is more consistently linked to rhinitis and conjunctivitis than to asthma.
However, some weather conditions, including thunderstorms, encourage rupture of pollen grains releasing smaller submicronic particles that can penetrate further into the lower airways. 34 These may explain the higher incidence of acute asthma exacerbations at these times. 109 Pollen allergy may also contribute to worsening asthma control during peak seasons through its impact on AR control. 
| ALLERGIC SENSITIZATION PATTERNS IN STRA PHENOTYPES
Asthma is a heterogeneous disease and even among children with STRA there are large variations in clinical characteristics and responses to treatments. 2, 115, 116 This has led to the idea that there are different asthma phenotypes with shared characteristics and pathophysiological mechanisms. In a study of children with asthma and at least one sensitization in the Trousseau Asthma Program cohort, two phenotypes of STRA were identified: "severe asthma with multiple allergies" associated with increased inflammatory markers (sIgE and FENO), impaired lung function, comorbid eczema, allergy to aeroallergens and the presence of mould in the home; and "severe exacerbations with pollen sensitization" associated with lower inflammatory markers but increased incidence of hospitalization for exacerbations of asthma and the highest incidence of food and pollen allergy. 22 They also identified two mild asthma phenotypes: "mild asthma with HDM monosensitization" was the largest group, with the lowest asthma severity and lowest prevalence of eczema and FA; and "mild asthma with multiple allergic sensitizations" with lower IgE and FENO and higher lung function than "severe asthma with multiple allergies" and no association with allergic comorbidities. 22 It was suggested the sensitizations in this latter group may represent asymptomatic sensitizations rather than clinically relevant allergy given the lower level of atopy in this group (lower IgE and fewer allergic comorbidities) compared to the SA group. 22 So STRA was associated with multiple allergies, including to moulds, and the presence of allergic comorbidities. In the Inner-City Asthma Consortium Asthma Phenotypes in the Inner City (APIC) study, cluster analysis of children with guidelines-managed asthma and rhinitis from nine urban areas of the United States was performed. 117 Five asthma phenotypes were identified. Four groups BONNER AND ROBERTS | 1599
were distinguished by progressively higher asthma severity, degree of allergic sensitization, allergic inflammation, bronchial hyperresponsiveness, eczema, food allergy and AR. This progressed from a "mild asthma and rhinitis, normal lung function and minimally atopic" group up to the most severe "treatment-unresponsive asthma, severely impaired lung function, highly allergic" group. The fifth group differed significantly from the others as they had highly symptomatic asthma despite high doses of medications but few allergies and minimally abnormal lung function. This group had slightly higher exposure to environmental tobacco smoke, which may have contributed to their asthma severity.
Four other studies attempting to identify asthma phenotypes have used cluster approaches, and each identified a phenotype with characteristics similar to the 'severe asthma with multiple allergies" phenotype, either combined with or alongside a "severe exacerbations" phenotype. 23, [118] [119] [120] Phenotypes with predominantly STRA were mostly characterized by increased allergic sensitization, predominant eosinophilic airway inflammation and impaired lung function. However, similar to the APIC study, another phenotype of STRA was identified in several of these studies which involved less allergic sensitization, fewer allergic comorbidities and lower predominance of eosinophilic airway inflammation. 24, 115, 116, 119 This highlights the heterogeneity of STRA and suggests that whilst allergy may be an important factor in STRA for many children, it is not likely to be driving STRA in all children. It is important to note that the asthma phenotypes in these studies partially overlapped in terms of asthma severity and clinical presentation, with a proportion of children sharing characteristics of more than one group, and no single phenotype corresponded completely with the definitions of STRA proposed in recent guidelines. Potential reasons for the slight differences between phenotypes identified in different studies are differences in study inclusion criteria, and inconsistent inclusion of variables likely to impact on asthma severity. 117, 121 Cluster analysis may also fail to uncover variables that interact in a complex manner to impact on asthma severity, for example not including exposure to allergens when considering the relationship between sensitization and asthma severity may mean the link between allergy and STRA phenotypes is less clear. 117 Despite this, these phenotyping studies have the potential to improve our understanding of the factors underlying STRA and how they may be modified to improve asthma control. 122, 123 Longitudinal studies of childhood asthma are needed to confirm the value of these phenotypes in assessment and management of STRA in clinical practice.
| SUMMARY
We found the most evidence for a link between AR and STRA in children. It is possible that the relationship is causal as increasing severity of AR is associated with increasing severity of asthma, there are plausible biological mechanisms for a causal link, and the association remains after adjustment for atopy. An association between eczema and more severe asthma can be seen but this is likely to be due to shared underlying atopic tendencies. There is growing evidence to support a relationship between FA and STRA, with FA seeming to be particularly associated with severe asthma exacerbations in children, but more research is needed to understand the underlying mechanism. The aeroallergen most implicated in STRA is mould, with exposure in sensitized children implicated in severe exacerbations as well as severe persistent asthma as part of the SAFS and "severe asthma with multiple allergies" phenotypes of STRA. There are multiple plausible mechanisms, both allergic and nonallergic, through which mould exposure may drive STRA. Pollen allergy is also associated with acute severe exacerbations of asthma and likely also contributes to STRA indirectly through AR severity.
Pet allergy seems to be associated with STRA in some sensitized children and can even affect those from pet-free homes. Allergies to pests including mouse and cockroach also seem to be an important factor in STRA for some children, particularly in low socioeconomic urban areas. HDM allergy has been associated with asthma symptoms but does not seem to be a risk factor for ongoing STRA. However, sensitization and exposure to any of the three key aeroallergens: HDM, pollens or moulds, increase the risk of severe asthma exacerbations during viral respiratory tract infections. severe asthma compared to a control intervention (difference of days −0.99 per month, P < 0.001). 125 An approach to identify and manage allergic triggers in STRA is summarized in Box 2.
| Implications for the clinician

| Future developments
There are several problems to overcome in order to fully under- There is substantial evidence that allergy is an important factor driving STRA and it is likely that STRA phenotypes are, at least in part, differentiated by the type and number of allergic sensitizations and presence and severity of allergic comorbidities. Improved understanding of these STRA phenotypes will hopefully translate into the clinical setting, where identifying an individual child's asthma phenotype could help predict their risk of severe exacerbations, identify the allergic comorbidities and sensitizations that are most important for their asthma control and allow allergen avoidance and treatment to focus on these triggers. 22 For example, children with the "severe exacerbations" phenotype and sensitization to food or aeroallergens may benefit from Omalizumab. 22 Potentially specific immunotherapy may be useful in those with limited clinically important allergens possibly under Omalizumab cover to reduce systemic allergic responses. All children with uncontrolled asthma despite treatment with 800 μg/day of inhaled budesonide (or equivalent) should be evaluated by a paediatric respiratory specialist and the accuracy of the diagnosis of asthma checked. 5, 8, 14 Focus should be placed on the following allergy associated issues:
1. Detailed assessment of allergic status:
• A thorough history to establish: previous reactions to allergens (specifically foods, animals/pets/pests, moulds, pollens and HDM), exposures to allergens at home and in the community (pets, hobbies, visits to homes of others) and any symptoms suggestive of allergic rhinoconjunctivitis.
• Specific IgE testing for likely aeroallergens and potential food allergens by SPT and/or specific IgE tests. 14, 126, 127 2. Management of any coexisting allergies:
• Avoidance of aeroallergens where possible with appropriate education for the family.
• Management of coexisting allergic rhinoconjunctivitis with oral antihistamine, intranasal steroid and/or antihistamine and ocular antihistamine or cromoglycate as required.
50
• Management of coexisting food allergy including avoidance advice, personal management plan for allergic reactions and access to self-injectable adrenaline.
128-130
• Management of SAFS with avoidance of moulds where possible, including interventions in homes with visible mould, avoidance of mouldy vegetation including stables and cleaning spacer equipment. Antifungal therapy may need to be considered though evidence for itraconazole and voriconazole in children is weak and may be associated with significant side-effects. 9, 95, 131 3. Consider additional therapy to reduce the impact of allergy and optimize asthma control:
• Omalizumab, a monoclonal antibody that binds circulating free IgE, has been successful in improving asthma control in atopic children ≥6 years with STRA. 7 However, not all children adequately respond to Omalizumab. 14, 16 • Mepolizumab, Reslizumab and Benralizumab are newer monoclonal antibodies targeting interleukin-5, but there is currently minimal data on their efficacy in paediatric STRA.
132-137
• Subcutaneous or sublingual immunotherapy to symptomatic aeroallergens may reduce asthma severity in children with mild-moderate asthma 72, 138, 139 but safety concerns surround the use of immunotherapy in STRA.
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targeting these might lead to improvements in asthma control. Identifying STRA phenotypes and their allergic triggers in clinical practice will be key to further improvement and personalization of STRA treatment.
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